A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas

被引:82
|
作者
Alchanati, I.
Nallar, S. C.
Sun, P.
Gao, L.
Hu, J.
Stein, A.
Yakirevich, E.
Konforty, D.
Alroy, I.
Zhao, X.
Reddy, S. P.
Resnick, M. B.
Kalvakolanu, D. V.
机构
[1] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[2] Proteol Ltd, Rehovot, Israel
[3] Jilin Univ, Sch Basic Med, Dept Pathophysiol, Changchun 130023, Peoples R China
[4] Carmel Hosp, Dept Urol, Haifa, Israel
[5] Rhode Isl Hosp, Dept Pathol, Providence, RI 02902 USA
[6] Brown Univ, Sch Med, Providence, RI 02912 USA
[7] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA
关键词
cell growth; cancer; cytokines; tumor suppression; transcription;
D O I
10.1038/sj.onc.1209708
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gene associated with retinoid interferon-induced mortality (GRIM)-19, an inhibitor of transcription factor STAT3, was originally identified as a critical regulatory protein in a genetic screen that was designed to identify the gene products necessary for Interferon (IFN)-beta-and retinoic acid-induced cell death. Over expression of GRIM-19 activates cell death. Conversely, inactivation of its expression promotes cell growth. STAT3 is a transcription factor that regulates gene expression in response to multiple extra cellular growth factors. In contrast to its normal feedback inhibition, a constitutive activation of STAT3 has been documented in several tumors. Although many STAT3-inhibitors are described, their relevance to human cancer is unclear. In an attempt to de. ne the molecular alterations associated with human renal cell carcinoma (RCC) using mass spectrometry, we have discovered that expression of GRIM-19 is lost or severely depressed in a number of primary RCC and in some urinogenital tumors. Using an RCC cell line, we show that down regulation of GRIM-19 promotes tumor growth via an augmentation of STAT3-dependent gene expression. These studies for the. rst time show a tumor-suppressor like activity of GRIM-19.
引用
收藏
页码:7138 / 7147
页数:10
相关论文
共 50 条
  • [31] Loss of caspase-1 gene expression in human gastric carcinomas and cell lines
    Jee, CD
    Lee, HY
    Bae, SI
    Yang, HK
    Lee, YM
    Rho, MS
    Kim, WH
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (05) : 1265 - 1271
  • [32] IMMUNOHISTOCHEMICAL ANALYSIS OF THE EXPRESSION OF RAS ONCOGENES IN HUMAN RENAL-CELL CARCINOMAS
    MORIYAMA, N
    KUZUMAKI, N
    HIRANO, H
    KURIMOTO, S
    UEKI, T
    NAGASE, Y
    KAJI, A
    OKAWA, N
    MATSUYAMA, N
    TAJIMA, A
    ASO, Y
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 1992, 25 (05) : 591 - 599
  • [33] The IFN-β and retinoic acid-induced cell death regulator GRIM-19 is upregulated during focal cerebral ischemia
    Mehrabian, Zara
    Chandrasekaran, Krish
    Kalakonda, Sudhakar
    Kristian, Tibor
    Fiskum, Gary
    Kalvakolanu, Dhananjaya V.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2007, 27 (05): : 383 - 391
  • [34] A stem cell gene expression profile of human squamous cell carcinomas
    Jensen, Kim B.
    Jones, Judith
    Watt, Fiona M.
    CANCER LETTERS, 2008, 272 (01) : 23 - 31
  • [35] Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3
    Kalakonda, Sudhakar
    Nallar, Shreeram C.
    Lindner, Daniel J.
    Hu, Jiadi
    Reddy, Sekhar P.
    Kalvakolanu, Dhananjaya V.
    CANCER RESEARCH, 2007, 67 (13) : 6212 - 6220
  • [36] Loss of heterozygosity of the nm23-H1 gene in human renal cell carcinomas
    Bosnar, MH
    Pavelic, K
    Hrascan, R
    Zeljko, Z
    Krhen, I
    Marekovic, Z
    Krizanac, S
    Pavelic, J
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1997, 123 (09) : 485 - 488
  • [37] Characterization of monoclonal antibodies against GRIM-19, a novel IFN-β and retinoic acid-activated regulator of cell death
    Hu, JD
    Angell, JE
    Zhang, J
    Ma, XR
    Seo, TG
    Raha, A
    Hayashi, J
    Choe, J
    Kalvakolanu, DV
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (10): : 1017 - 1026
  • [38] Loss of heterozygosity of thenm23-H1 gene in human renal cell carcinomas
    Maja Herak Bosnar
    Krešimir Pavelić
    Reno Hrašćan
    Žarko Zeljko
    Ivan Krhen
    Zvonimir Mareković
    Šimun Križanac
    Jasminka Pavelić
    Journal of Cancer Research and Clinical Oncology, 1997, 123 : 485 - 488
  • [39] β-catenin expression and mutational analysis in renal cell carcinomas
    Kim, YS
    Kang, YK
    Kim, JB
    Han, SA
    Kim, KII
    Paik, SR
    PATHOLOGY INTERNATIONAL, 2000, 50 (09) : 725 - 730
  • [40] Proteomic analysis of drug metabolizing networks in renal cell carcinomas with differential drug sensitivity and VHL expression
    Nagaprashantha, L. Dalasanur
    Singhal, J.
    Vatsyayan, R.
    Lelsani, P.
    Singhal, S. S.
    Prokai, L.
    Awasthi, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)